- Supported exchanges /
- ST /
- CINPHA.ST
Cinclus Pharma (CINPHA ST) stock market data APIs
kr19.42
-0.59(-2.9%)
as of November 22, 2024
Price chart is built with Anychart
Cinclus Pharma Holding AB (publ), a clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases. Its lead product is linaprazan glurate for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer bacteria Helicobacter pylori (H. pylori). The company was founded in 2014 and is based in Stockholm, Sweden.
Cinclus Pharma Financial Data Overview
20.46 | |
19.42 | |
- | |
19.97 | |
19.82 | |
19.214-42 | |
0 | |
0 | |
0 | |
-0.7853 | |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'CINPHA',
Type:
'Common Stock',
Name:
'Cinclus Pharma',
Exchange:
'ST',
CurrencyCode:
'SEK',
CurrencyName:
'Swedish krone',
CurrencySymbol:
'kr',
CountryName:
'Sweden',
CountryISO:
'SE',
OpenFigi:
NULL,
ISIN:
NULL,
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - Specialty & Generic',
}
Cinclus Pharma Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cinclus Pharma Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Cinclus Pharma End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: